At StemX Bio, they are transforming drug discovery with our ready-to-use human pancreas microtissue model. Their innovative approach, backed by a patent-pending differentiation protocol, empowers researchers to rapidly advance from screening to clinical trials.
StemX Bio’s human microtissue models offer unmatched predictive value, robustness, and scalability, accelerating the development of effective and safer therapies for diabetes.
